138 related articles for article (PubMed ID: 9111190)
21. Disposition of butadiene epoxides in Sprague-Dawley rats following exposures to 8000 ppm 1,3-butadiene: comparisons with tissue epoxide concentrations following low-level exposures.
Thornton-Manning JR; Dahl AR; Allen ML; Bechtold WE; Griffith WC; Henderson RF
Toxicol Sci; 1998 Feb; 41(2):167-73. PubMed ID: 9520352
[TBL] [Abstract][Full Text] [Related]
22. Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure.
Koivisto P; Kilpeläinen I; Rasanen I; Adler ID; Pacchierotti F; Peltonen K
Carcinogenesis; 1999 Jul; 20(7):1253-9. PubMed ID: 10383898
[TBL] [Abstract][Full Text] [Related]
23. DNA adducts in rats and mice following exposure to [4-14C]-1,2-epoxy-3-butene and to [2,3-14C]-1,3-butadiene.
Boogaard PJ; de Kloe KP; Booth ED; Watson WP
Chem Biol Interact; 2004 Jun; 148(1-2):69-92. PubMed ID: 15223358
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation.
Thornton-Manning JR; Dahl AR; Bechtold WE; Griffith WC; Henderson RF
Toxicology; 1997 Nov; 123(1-2):125-34. PubMed ID: 9347927
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
Filser JG; Hutzler C; Meischner V; Veereshwarayya V; Csanády GA
Chem Biol Interact; 2007 Mar; 166(1-3):93-103. PubMed ID: 16616907
[TBL] [Abstract][Full Text] [Related]
26. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
Bond JA; Csanády GA; Leavens T; Medinsky MA
IARC Sci Publ; 1993; (127):45-55. PubMed ID: 8070886
[TBL] [Abstract][Full Text] [Related]
27. Identification of novel metabolites of butadiene monoepoxide in rats and mice.
Richardson KA; Peters MM; Megens RH; van Elburg PA; Golding BT; Boogaard PJ; Watson WP; van Sittert NJ
Chem Res Toxicol; 1998 Dec; 11(12):1543-55. PubMed ID: 9860500
[TBL] [Abstract][Full Text] [Related]
28. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
Bond JA; Medinsky MA
Chem Biol Interact; 2001 Jun; 135-136():599-614. PubMed ID: 11397415
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of butadiene monoxide by freshly isolated hepatocytes from mice and rats: different partitioning between oxidative, hydrolytic, and conjugation pathways.
Kemper RA; Krause RJ; Elfarra AA
Drug Metab Dispos; 2001 Jun; 29(6):830-6. PubMed ID: 11353751
[TBL] [Abstract][Full Text] [Related]
30. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
Motwani HV; Törnqvist M
Toxicol Appl Pharmacol; 2014 Dec; 281(3):276-84. PubMed ID: 25448046
[TBL] [Abstract][Full Text] [Related]
31. Species difference in the ovarian toxicity of 1,3-butadiene epoxides in B6C3F1 mice and Sprague-Dawley rats.
Doerr JK; Hollis EA; Sipes IG
Toxicology; 1996 Oct; 113(1-3):128-36. PubMed ID: 8901892
[TBL] [Abstract][Full Text] [Related]
32. Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates.
Kohn MC; Melnick RL
Toxicology; 1996 Oct; 113(1-3):31-9. PubMed ID: 8901880
[TBL] [Abstract][Full Text] [Related]
33. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
34. Hepatic and pulmonary glutathione conjugation of 1,2:3,4-diepoxybutane in human, rat, and mouse in vitro.
Boogaard PJ; Sumner SC; Turner MJ; Bond JA
Toxicology; 1996 Oct; 113(1-3):297-9. PubMed ID: 8901912
[TBL] [Abstract][Full Text] [Related]
35. Physiologically based pharmacokinetic modeling of blood and tissue epoxide measurements for butadiene.
Sweeney LM; Himmelstein MW; Schlosser PM; Medinsky MA
Toxicology; 1996 Oct; 113(1-3):318-21. PubMed ID: 8901917
[TBL] [Abstract][Full Text] [Related]
36. 1,2:3,4-Diepoxybutane in blood of male B6C3F1 mice and male Sprague-Dawley rats exposed to 1,3-butadiene.
Csanády GA; Steinhoff R; Riester MB; Semder B; Pütz C; Li Q; Richter N; Kessler W; Klein D; Filser JG
Toxicol Lett; 2011 Dec; 207(3):286-90. PubMed ID: 21983653
[TBL] [Abstract][Full Text] [Related]
37. N-terminal globin adducts as biomarkers for formation of butadiene derived epoxides.
Boysen G; Georgieva NI; Upton PB; Walker VE; Swenberg JA
Chem Biol Interact; 2007 Mar; 166(1-3):84-92. PubMed ID: 17084829
[TBL] [Abstract][Full Text] [Related]
38. PBPK model for butadiene metabolism to epoxides: quantitative species differences in metabolism.
Johanson G; Filser JG
Toxicology; 1996 Oct; 113(1-3):40-7. PubMed ID: 8901881
[TBL] [Abstract][Full Text] [Related]
39. Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene.
Nauhaus SK; Fennell TR; Asgharian B; Bond JA; Sumner SC
Chem Res Toxicol; 1996 Jun; 9(4):764-73. PubMed ID: 8831821
[TBL] [Abstract][Full Text] [Related]
40. Germ cell mutagenicity of three metabolites of 1,3-butadiene in the rat: induction of spermatid micronuclei by butadiene mono-, di-, and diolepoxides in vivo.
Lähdetie J; Peltonen K; Sjöblom T
Environ Mol Mutagen; 1997; 29(3):230-9. PubMed ID: 9142165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
